News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,796 Results
Type
Article (43483)
Company Profile (347)
Press Release (668966)
Section
Business (212005)
Career Advice (2167)
Deals (37034)
Drug Delivery (103)
Drug Development (83941)
Employer Resources (173)
FDA (16613)
Job Trends (15531)
News (359233)
Policy (34336)
Tag
Academia (2608)
Alliances (51723)
Alzheimer's disease (1258)
Approvals (16533)
Artificial intelligence (145)
Bankruptcy (368)
Best Places to Work (11744)
Biotechnology (221)
Breast cancer (123)
Cancer (1130)
Cardiovascular disease (105)
Career advice (1804)
Cell therapy (245)
Clinical research (66686)
Collaboration (405)
Compensation (205)
COVID-19 (2625)
C-suite (97)
Data (1141)
Diabetes (162)
Diagnostics (6256)
Drug pricing (96)
Earnings (86943)
Employer resources (152)
Events (113538)
Executive appointments (319)
FDA (17163)
Funding (365)
Gene therapy (192)
GLP-1 (648)
Government (4514)
Healthcare (18998)
Infectious disease (2716)
Inflammatory bowel disease (112)
Interviews (337)
IPO (16738)
Job creations (4157)
Job search strategy (1550)
Layoffs (449)
Legal (8463)
Lung cancer (179)
Manufacturing (190)
Medical device (13310)
Medtech (13315)
Mergers & acquisitions (20367)
Metabolic disorders (453)
Neuroscience (1549)
NextGen Class of 2024 (6714)
Non-profit (4540)
Northern California (1493)
Obesity (264)
Opinion (222)
Patents (109)
People (58755)
Pharmaceutical (102)
Phase I (20727)
Phase II (29310)
Phase III (21960)
Pipeline (462)
Postmarket research (2674)
Preclinical (8776)
Radiopharmaceuticals (245)
Rare diseases (234)
Real estate (6349)
Regulatory (22704)
Research institute (2382)
Resumes & cover letters (370)
Southern California (1310)
Startups (3780)
United States (13770)
Vaccines (580)
Weight loss (210)
Date
Today (1)
Last 7 days (679)
Last 30 days (3602)
Last 365 days (36610)
2024 (33626)
2023 (40928)
2022 (52113)
2021 (56676)
2020 (55112)
2019 (47824)
2018 (36140)
2017 (33570)
2016 (33169)
2015 (39010)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (804)
Arizona (201)
Asia (40965)
Australia (6498)
California (3372)
Canada (1305)
China (259)
Colorado (150)
Connecticut (157)
Europe (87634)
Florida (467)
Georgia (116)
Illinois (352)
Indiana (207)
Maryland (587)
Massachusetts (2666)
Michigan (159)
Minnesota (275)
New Jersey (976)
New York (969)
North Carolina (747)
Northern California (1493)
Ohio (142)
Pennsylvania (852)
South America (1179)
Southern California (1310)
Texas (479)
Washington State (371)
712,796 Results for "erytech pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma
ERYTECH Pharma, announced that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma.
June 14, 2023
·
4 min read
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Press Releases
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
November 8, 2024
·
12 min read
Pharm Country
Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community
Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.
May 23, 2024
·
6 min read
1 of 71,280
Next
